Showing 2642 results
- Key Release /Ad hoc announcement pursuant to Art. 53 LR Phase III PSMAfore trial with PluvictoTM met the primary endpoint of radiographic progression-free survival (rPFS) in PSMA–positive mCRPC who have been…
- Media Release /Shareholders approve 26th consecutive dividend increase to CHF 3.20 (+3.2%) per share for 2022; representing a 4.0% yield1 and approximately 61% payout of free cash flow Shareholders confirm Joerg…
- Media Release /Les actionnaires approuvent la 26e augmentation consécutive du dividende à CHF 3,20 (+3,2%) par action pour 2022 ; représentant un rendement de 4.0%1 et une distribution du free cash-flow d…
- Featured News /
Novartis announced the company’s financial results for the second quarter and first half of 2021.
- Featured News /
Novartis is committed to transforming the lives of people living with blood cancers and serious blood disorders.
- In The News /Novartis CEO Vas Narasimhan discusses how to improve pandemic preparedness at the CNBC Evolve Global Summit.
- Biography /
- Media Library /
Pagination
- ‹ Previous page
- 1
- …
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- …
- 265
- › Next page